|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.092 AUD | -3.16% |
|
-3.16% | -7.07% |
| Mar. 06 | BCAL Diagnostics Appoints CEO | MT |
| Feb. 20 | BCAL Diagnostics Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
BCAL Diagnostics Limited reported earnings results for the half year ended December 31, 2022. For the half year, the company reported sales was AUD 1.01 million compared to AUD 0.409334 million a year ago. Net loss was AUD 2.47 million compared to AUD 1.32 million a year ago.
Basic loss per share from continuing operations was AUD 0.0117 compared to AUD 0.006 a year ago. Diluted loss per share from continuing operations was AUD 0.0117 compared to AUD 0.006 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -7.07% | 15.63M | |
| +1.69% | 12.8B | |
| -7.57% | 7.61B | |
| +3.22% | 5.41B | |
| +0.93% | 4.51B | |
| +8.48% | 4.49B | |
| +9.21% | 2.73B | |
| -13.87% | 2.02B | |
| -11.63% | 1.73B | |
| +3.45% | 1.64B |
BCAL DIAGNOSTICS LIMITED 
